Market Price

66.40 

0.20 0.3%

as of Dec 05 '19

52 Week Range:

48.95 77.00


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

STRATEC SE designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany and internationally. The company operates in three segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. The Diatron segment offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications. The Smart Consumables segment develops and manufactures smart consumables in the fields of diagnostics, life sciences, and medical technology. STRATEC SE also develops workflow software for networking various analyzer systems, as well as develops and sells scientific materials and technologies. The company was formerly known as STRATEC Biomedical AG and changed its name to STRATEC SE in December 2018. STRATEC SE was founded in 1979 and is headquartered in Birkenfeld, Germany.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Equity (BVPS) 4.42
5.21
6.23
7.10
7.57
8.15
9.00
10.45
11.13
12.46
12.32
growth rate 17.9% 19.6% 14.0% 6.6% 7.7% 10.4% 16.1% 6.5% 12.0% -1.1%
Earnings BIT 14.52
15.10
17.55
21.13
17.36
19.97
21.25
26.93
23.73
26.47
15.57
growth rate 4.0% 16.2% 20.4% -17.8% 15.0% 6.4% 26.7% -11.9% 11.6% -41.2%
Avg.PE 15.50
26.04
28.57
24.33
31.65
23.04
28.02
26.62
46.62
32.55
49.31
growth rate 68.0% 9.7% -14.8% 30.1% -27.2% 21.6% -5.0% 75.1% -30.2% 51.5%
ROA 14.60
14.99
14.13
14.57
12.00
12.92
15.47
14.89
9.39
9.83
3.33
growth rate 2.7% -5.7% 3.1% -17.6% 7.7% 19.7% -3.8% -36.9% 4.7% -66.1%
ROE 20.29
21.38
19.88
19.70
15.95
16.36
18.90
18.23
14.29
17.00
5.79
growth rate 5.4% -7.0% -0.9% -19.0% 2.6% 15.5% -3.5% -21.6% 19.0% -65.9%
ROIC 19.97
21.53
20.07
20.13
14.59
15.07
17.59
17.06
11.31
11.88
4.26
growth rate 7.8% -6.8% 0.3% -27.5% 3.3% 16.7% -3.0% -33.7% 5.0% -64.1%
Cur. Ratio 4.47
3.65
4.17
4.78
4.55
5.52
5.78
5.79
1.12
4.08
3.26
growth rate -18.3% 14.3% 14.6% -4.8% 21.3% 4.7% 0.2% -80.7% 264.3% -20.1%
Quick Ratio 2.65
2.00
2.13
2.49
2.18
3.69
4.38
4.54
0.78
2.97
1.55
growth rate -24.5% 6.5% 16.9% -12.5% 69.3% 18.7% 3.7% -82.8% 280.8% -47.8%
Leverage 1.40
1.45
1.38
1.33
1.32
1.21
1.23
1.22
1.79
1.67
1.81
growth rate 3.6% -4.8% -3.6% -0.8% -8.3% 1.7% -0.8% 46.7% -6.7% 8.4%
Balance Sheet Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Acct.Receivable 9.68
9.91
23.00
23.00
30.00
29.01
21.24
27.06
47.98
50.18
41.32
growth rate 2.4% 132.1% 0.0% 30.4% -3.3% -26.8% 27.4% 77.3% 4.6% -17.7%
Acct.Payable 3.00
4.00
4.00
4.41
2.86
4.15
8.74
11.86
10.10
growth rate 33.3% 0.0% 10.3% -35.3% 45.2% 110.7% 35.7% -14.8%
Cur.Assets 59.48
69.93
72.00
82.00
62.00
69.33
90.01
108.15
105.93
116.98
127.19
growth rate 17.6% 3.0% 13.9% -24.4% 11.8% 29.8% 20.2% -2.1% 10.4% 8.7%
Total Assets 70.00
85.80
99.00
111.00
108.00
117.79
137.75
158.94
257.97
263.78
275.29
growth rate 22.6% 15.4% 12.1% -2.7% 9.1% 17.0% 15.4% 62.3% 2.3% 4.4%
Cash 19.20
21.20
13.00
20.00
13.00
20.73
46.64
56.42
26.50
24.14
23.82
growth rate 10.4% -38.7% 53.9% -35.0% 59.5% 124.9% 21.0% -53.0% -8.9% -1.3%
Inventory 24.09
31.64
35.00
39.00
18.00
18.09
18.07
16.02
24.52
27.88
58.53
growth rate 31.3% 10.6% 11.4% -53.9% 0.5% -0.1% -11.3% 53.1% 13.7% 109.9%
Cur.Liabilities 13.31
19.15
17.00
17.00
12.00
12.56
15.59
18.67
94.20
28.70
39.05
growth rate 43.9% -11.2% 0.0% -29.4% 4.7% 24.1% 19.8% 404.6% -69.5% 36.1%
Liabilities 20.10
26.50
27.00
28.00
21.00
20.61
25.70
28.66
115.63
105.94
123.08
growth rate 31.8% 1.9% 3.7% -25.0% -1.9% 24.7% 11.5% 303.5% -8.4% 16.2%
LT Debt 5.66
0.00
7.00
9.00
7.00
6.64
4.00
3.61
2.51
61.53
68.53
growth rate -100.0% 28.6% -22.2% -5.1% -39.8% -9.7% -30.7% 2,356.5% 11.4%
Equity 49.90
59.30
71.90
83.20
87.50
97.18
112.05
130.28
142.34
157.84
152.20
growth rate 18.8% 21.3% 15.7% 5.2% 11.1% 15.3% 16.3% 9.3% 10.9% -3.6%
Common Shares 11.00
11.00
12.00
12.00
12.00
12.00
12.00
12.00
12.00
12.00
12.00
growth rate 0.0% 9.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Capital Expenditures 0.90
1.90
8.00
2.00
3.00
2.58
1.47
5.44
7.21
9.31
11.01
growth rate 111.1% 321.1% -75.0% 50.0% -14.2% -42.8% 268.9% 32.5% 29.2% 18.3%
Cash Dividends 2.50
4.00
5.12
5.80
6.40
6.57
7.06
8.25
8.89
9.13
9.53
growth rate 60.0% 28.0% 13.3% 10.3% 2.6% 7.5% 16.9% 7.7% 2.8% 4.4%
Cash From OA 4.20
10.90
1.00
11.00
9.00
23.84
39.75
26.03
16.26
29.98
11.95
growth rate 159.5% -90.8% 1,000.0% -18.2% 164.9% 66.8% -34.5% -37.6% 84.4% -60.1%
FCF per Share 0.83
0.25
-0.03
-0.05
0.45
1.00
1.80
2.45
0.49
1.48
0.09
growth rate -69.9% -100.0% 0.0% 100.0% 122.2% 80.0% 36.1% -80.0% 202.0% -93.9%
Sale Purchase of Stock 0.80
0.69
1.67
0.25
1.81
growth rate -13.7% 141.6% -84.8% 612.6%
FCF 3.00
9.00
-6.00
8.00
0.20
14.00
33.00
17.00
6.00
14.00
-7.00
growth rate 200.0% -100.0% 100.0% -97.5% 6,900.0% 135.7% -48.5% -64.7% 133.3% -100.0%
Income Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Sales 61.00
87.20
104.00
117.00
123.00
127.95
144.86
146.89
184.91
207.48
187.82
growth rate 43.0% 19.3% 12.5% 5.1% 4.0% 13.2% 1.4% 25.9% 12.2% -9.5%
Op.Income 4.60
14.70
13.00
15.00
12.00
19.97
21.25
26.93
23.73
26.47
15.57
growth rate 219.6% -11.6% 15.4% -20.0% 66.4% 6.4% 26.7% -11.9% 11.6% -41.2%
IBT 9.40
15.10
17.55
21.10
15.30
19.33
24.05
27.17
22.85
28.99
14.09
growth rate 60.6% 16.2% 20.2% -27.5% 26.4% 24.4% 13.0% -15.9% 26.9% -51.4%
Net Income 6.10
11.70
13.00
15.00
12.00
15.48
19.77
22.08
19.50
25.64
8.97
growth rate 91.8% 11.1% 15.4% -20.0% 29.0% 27.7% 11.7% -11.7% 31.5% -65.0%
EPS 0.54
1.02
1.12
1.31
1.06
1.31
1.67
1.85
1.63
2.14
0.75
growth rate 88.9% 9.8% 17.0% -19.1% 23.6% 27.5% 10.8% -11.9% 31.3% -65.0%
Gross Profit 67.60
44.20
53.00
40.00
39.00
41.76
44.94
55.03
61.56
64.75
53.48
growth rate -34.6% 19.9% -24.5% -2.5% 7.1% 7.6% 22.5% 11.9% 5.2% -17.4%
R&D 3.50
3.50
5.05
5.02
8.34
8.05
9.90
9.24
growth rate 0.0% 44.2% -0.6% 66.2% -3.4% 22.9% -6.7%

Quarterly Statements

Item Name Sep '18 Dec '18 Mar '19 Jun '19 Sep '19
Earnings BIT 4.35
7.20
2.08
4.82
4.17
growth rate 65.4% -71.1% 132.0% -13.5%
Balance Sheet Sep '18 Dec '18 Mar '19 Jun '19 Sep '19
Acct.Receivable 40.77
41.32
48.47
47.94
53.05
growth rate 1.4% 17.3% -1.1% 10.7%
Acct.Payable 12.21
10.10
11.20
10.91
14.22
growth rate -17.3% 10.9% -2.6% 30.3%
Cur.Assets 124.47
127.19
135.29
124.43
130.02
growth rate 2.2% 6.4% -8.0% 4.5%
Total Assets 267.97
275.29
294.21
291.22
300.24
growth rate 2.7% 6.9% -1.0% 3.1%
Cash 25.08
23.82
25.02
20.38
16.31
growth rate -5.0% 5.1% -18.6% -20.0%
Inventory 55.31
58.53
60.84
54.96
59.63
growth rate 5.8% 4.0% -9.7% 8.5%
Cur.Liabilities 43.94
39.05
51.78
45.32
44.41
growth rate -11.1% 32.6% -12.5% -2.0%
Liabilities 120.60
123.08
140.98
142.64
149.26
growth rate 2.1% 14.5% 1.2% 4.6%
LT Debt 59.98
68.53
74.85
75.18
89.09
growth rate 14.3% 9.2% 0.4% 18.5%
Equity 147.37
152.20
153.23
148.57
150.98
growth rate 3.3% 0.7% -3.0% 1.6%
Common Shares 11.96
11.97
11.97
12.01
12.02
growth rate 0.1% 0.0% 0.4% 0.0%
Cash Flow Statement Sep '18 Dec '18 Mar '19 Jun '19 Sep '19
Capital Expenditures 3.07
3.91
3.91
4.38
3.46
growth rate 27.4% 0.0% 11.9% -20.9%
Cash Dividends 9.81
9.81
9.81
9.81
growth rate 0.0% 0.0% 0.0%
Cash From OA 3.43
9.50
9.50
3.37
-1.79
growth rate 177.4% 0.0% -64.5% -100.0%
Sale Purchase of Stock
growth rate
FCF 0.36
5.59
5.59
-1.01
-5.25
growth rate 1,474.4% 0.0% -100.0% 0.0%
Income Statement Sep '18 Dec '18 Mar '19 Jun '19 Sep '19
Sales 45.70
53.19
47.68
62.69
50.69
growth rate 16.4% -10.4% 31.5% -19.2%
Op.Income 4.35
2.08
2.08
4.82
4.17
growth rate -52.2% 0.0% 132.0% -13.5%
IBT 4.09
1.62
1.62
5.01
3.63
growth rate -60.5% 0.0% 209.8% -27.6%
Net Income 2.79
3.32
-0.32
4.21
3.01
growth rate 19.3% -100.0% 100.0% -28.5%
EPS
growth rate
Gross Profit 15.08
14.21
11.12
13.69
13.24
growth rate -5.8% -21.7% 23.0% -3.3%
R&D 1.01
1.90
1.90
1.96
1.32
growth rate 87.7% 0.0% 3.2% -32.6%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

F (3.51)

YOY Growth Grade:

D (45.02)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 83.08 78.58 32.65
EPS / Growth 16.7% 0.85 66.4%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 7.4%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 7.4% 12.0% 12.0%
Future PE 14.78 28.36 28.36
Future EPS 1.72 2.63 2.63
Value Price
MOS %
6.30
-90.5%
18.44
-72.2%
18.44
-72.2%
MOS Price 3.15 9.22 9.22
IRT 26.05 19.75 19.75

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.